Carboplatin/Paclitaxel/Retifanlimab Regimen

Preferred Label : Carboplatin/Paclitaxel/Retifanlimab Regimen;

NCIt synonyms : Paclitaxel/Carboplatin Plus Retifanlimab; Carboplatin/Paclitaxel/Retifanlimab-dlwr; Carboplatin/Paclitaxel/Retifanlimab; Carboplatin-Paclitaxel-Retifanlimab; Carboplatin/Paclitaxel/Zynyz; Carboplatin/Paclitaxel Plus Retifanlimab-dlwr; Carboplatin/Paclitaxel Plus Retifanlimab;

NCIt definition : A regimen consisting of carboplatin, paclitaxel, and retifanlimab that may be used in the treatment of anal carcinoma.;

Détails

Origin ID

C213253;

chemotherapy_regimen_has_component
- Carboplatin [NCIt concept]
- Paclitaxel [NCIt concept]
- Retifanlimab [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients